Related Experiment Videos
[Newer antiepileptic drugs]
1Section of Biofunctional Informatics, Graduate School of Allied Health Sciences, Tokyo Medical and Dental University, 1 5 45 Yushima, Bunkyo-ku, Tokyo 113 8519, Japan.
No to Shinkei = Brain and Nerve
|February 24, 2007
Summary
Newer antiepileptic drugs offer broader efficacy and fewer interactions than older options. While some have specific restrictions, many newer drugs also treat neuropathic pain and offer mood stabilization.
Area of Science:
- Pharmacology
- Neurology
- Clinical Medicine
Background:
- Since the 1990s, ten novel antiepileptic drugs (AEDs) have emerged, offering improved therapeutic profiles over traditional AEDs.
- These newer AEDs generally exhibit wider therapeutic spectra, reduced side-effect profiles, and fewer drug-to-drug interactions.
- Notable examples include zonisamide (used since 1989 in Japan) and gabapentin (approved in 2006), with varying approval statuses globally.
Purpose of the Study:
- To review the characteristics, efficacy, safety, and additional therapeutic applications of newer antiepileptic drugs.
- To compare international treatment guidelines regarding the use of novel AEDs in epilepsy management.
- To highlight the potential of these newer agents beyond seizure control, including in neuropathic pain and mood disorders.
Main Methods:
- Comparative analysis of newer antiepileptic drugs based on published data and treatment guidelines.
- Review of drug approval status, efficacy (response and dropout rates), and safety profiles (adverse events, drug interactions).
- Examination of off-label and co-morbid applications, such as neuropathic pain, mood stabilization, and anxiety.
Main Results:
- Newer AEDs show overlapping response and dropout rates, with some (e.g., gabapentin, levetiracetam, pregabalin) renally eliminated and having minimal interactions.
- Specific drugs like felbamate and vigabatrin have significant safety concerns limiting their use in certain regions.
- Many newer AEDs demonstrate efficacy in neuropathic pain and possess mood-stabilizing or anxiolytic properties, suggesting broader CNS effects.
Conclusions:
- Newer antiepileptic drugs represent a significant advancement in epilepsy treatment, offering improved safety and broader applications.
- Treatment guidelines vary internationally, influencing the adoption of these newer agents.
- Beyond seizure suppression, newer AEDs show promise for managing co-morbidities like neuropathic pain and psychiatric symptoms, potentially offering neuroprotective benefits.
Related Concept Videos
01:08Antiepileptic Drugs: Sodium Channel Blockers
1.4K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.4K
01:14Antiepileptic Drugs: Glutamate Antagonists
787
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
787
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.1K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.1K
01:20Antiepileptic Drugs: Potassium Channel Activators
521
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
521
01:17Antiepileptic Drugs: Calcium Channel Blockers
998
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
998
01:24Epilepsy and Seizures: Overview
1.0K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.0K